Chemoimmunotherapy With Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Bendamustine and Rituximab (BR) In Previously Untreated and Physically Fit Patients (pts) With Advanced Chronic Lymphocytic Leukemia (CLL): Results Of a Planned Interim Analysis Of The CLL10 Trial, An International, Randomized Study Of The German CLL Study Group (GCLLSG)

Konference: 2013 55th ASH Annual Meeting - účast ČR

Kategorie: Maligní lymfomy a leukémie

Téma: 642. CLL: Therapy, excluding Transplantation: Chemoimmunotherapy Clinical Trials

Číslo abstraktu: 526

Autoři: MD Barbara Eichhorst; MD Anna-Maria Fink; Dipl.Math. Raymonde Busch, Ph.D.; M.D. Elisabeth Lange; Prof. Dr. Hubert Köppler; M.D. Michael Kiehl; M.D. Martin Soekler (Sökler); MD Rudolf Schlag; MD Ursula Vehling-Kaiser; M.D. Georg Köchling (Koechling); M.D. Christoph Plöger (Ploeger); M.D. Michael Gregor; MD Torben Plesner; Prof. MUDr. Marek Trněný, CSc.; M.D. Kirsten Fischer; Prof. Dr. med. Hartmut Döhner (Doehner); MD Michael Kneba, PhD; MD Clement Martin Wendtner; MD Wolfram Klapper, PhD; M.D. Karl-Anton Kreuzer; MD Stephan Stilgenbauer; MD Sebastian Böttcher; Prof. MD Michael Hallek

Datum přednesení příspěvku: 9. 12. 2013